C.H.I.C.K Program receives the 1st independently audited quality recognition >
For the first time, an AH company services program receives internationally recognized quality approval from Bureau Veritas.
Ceva sponsors IAHAIO Conference held in Paris >
Ceva reiterates its commitment to promoting the benefits of human-animal interaction (HAI)
Ceva posts strong double-digit organic growth once again in first half of 2016 >
Ceva sponsors the International Symposium on Marek’s Disease and Avian Herpes viruses organised by INRA, France >
11th International Symposium on Marek’s Disease and Avian Herpes viruses organized in Tours, France
Avian Flu - Ceva's reveals plans to develop new AI H7 vaccine during latest summit in Mexico >
Ceva gathered experts from around the world to share the latest findings on the global threat posed by Avian Influenza (AI)
Ceva acquires Biovac, leading French manufacturer of Autogenous vaccines >
Move will reinforce group’s AMR strategy to find alternative solutions to use of antibiotics
One Health put into practice: Veterinary and human cardiologists discuss cardiovascular disease in pets >
Paris, February 2016 - ‘Making tomorrow happen today’ was the theme of the human-veterinary cross-talk symposium organised by Ceva on February 19.
"Healthier flocks for healthy food" - Ceva Poultry Vaccinology Summit in Barcelona >
This Summit provided the first scientific evidence that vaccination in the hatchery with new technology vaccines can create a step change from disease protection to disease prevention, by minimizing the spread and therefore circulation of field viruses.
Ceva enters Indian market with acquisition of Polchem >
Strong customer technical support will provide a natural platform for the coming together of the 2 businesses.
Ceva reports annual growth of 12% and reaffirms ambition to enter the global top 5 by 2020 >
Raft of new product launches across significant markets powers strong sales in 2015